SPONTANEOUS MONITORING OF ADVERSE REACTIONS TO DRUGS BY ITALIAN DERMATOLOGISTS - A PILOT-STUDY

被引:4
作者
CAINELLI, T
机构
来源
DERMATOLOGICA | 1991年 / 182卷 / 01期
关键词
DERMATOLOGICAL SPONTANEOUS REPORTING SYSTEM; ADVERSE DRUG REACTIONS; POSTMARKETING SURVEILLANCE; BAMIFYLLINE; EXANTHEMA;
D O I
10.1159/000247729
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
During 1988, the Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED) coordinated a pilot study aimed at evaluating the feasibility of a system for spontaneous monitoring of adverse drug reactions in dermatological practice in Italy. Approximately 400 dermatologists were asked to collaborate, and 141 agreed to the study. Procedures similar to those well established in other surveillance programs (including the use of standard forms and standardized assessment procedure) were adopted. In a 2-month period 775 reports were collected, of which 711 were maintained after careful evaluation. The general profile of the adverse reactions reported was in accordance with the experience derived by other spontaneous surveillance programs. The main purpose of spontaneous reporting systems is the identification of new reactions, and a model analysis was proposed, in our study, with reference to skin reactions to bamifylline. The demonstration of the feasibility of a drug-monitoring program in Italy, where little tradition exists in the area, is the most important result of our study.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 20 条
[1]
RATES OF CUTANEOUS REACTIONS TO DRUGS - REPORT FROM BOSTON COLLABORATIVE DRUG SURVEILLANCE PROGRAM [J].
ARNDT, KA ;
JICK, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (09) :918-923
[2]
BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358
[3]
BIRIELL C, 1984, EPIDEMIOLOGIA FARMAC, P91
[4]
ADVERSE REACTION PROFILES OF DRUG ERUPTIONS [J].
BRUINSMA, W .
DERMATOLOGICA, 1972, 145 (06) :377-388
[5]
BRUINSMA W, 1985, MONITORING DRUG SAFE, P357
[6]
ELLINWOOD EH, 1988, MEYLERS SIDE EFFECTS, P1
[7]
GRIFFIN JP, 1985, ADVERSE DRUG REACT T, V4, P213
[8]
INMAN WHW, 1985, MONITORING DRUG SAFE
[9]
KARCH FE, 1977, CLIN PHARMACOL THER, V21, P247
[10]
REYNOLDS JEF, 1989, MARTINDALE EXTRA PHA, P1522